RIO DE JANEIRO, BRAZIL - The vaccine against the novel coronavirus is the most expected event of the year. But doubts remain and many people are concerned: who will be immunized first?
A report prepared by the prestigious Johns Hopkins Center for Health Security in the United States recommended that some groups should be prioritized for vaccination. According to experts, once a vaccine is approved, supply will be limited at the outset, even if there is more than one option. Bottlenecks in the manufacturing process stages, including shortage of vials and syringes, or issues in the bottling and finishing process, could . . .